Integra Lifesciences Holdings Corporation · NASDAQ:IART

Integra Lifesciences — Investor Presentation (September 2026)

54 slides from Integra Lifesciences's investor presentation, Sep 8, 2026

  1. Slide 1: Investor Presentation September 2026

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  2. Slide 2: Safe Harbor Statement

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  3. Slide 3: Non-GAAP Financial Measures

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  4. Slide 4: Executive summary

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  5. Slide 5: Business overview

    /Admin/ADVANCED GRAPHICS FILES/Cover and Template/2026/2026_03/4714660-001_Integra_Chelsea Lin_Dividers Business overview 01 These materials are not to be printed, downloaded or distributed. These materials are only available to QIBs and non-US persons.

  6. Slide 6: A global MedTech leader dedicated to restoring lives

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  7. Slide 7: Evolution of Integra: Building a scaled specialty platform

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  8. Slide 8: Leading player in attractive, niche markets through focus

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  9. Slide 9: Leadership in attractive, niche markets through differentiated technologies

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  10. Slide 10: Focused execution enabling innovation and growth

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  11. Slide 11: Delivering our vision in 2026 and beyond

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  12. Slide 12: Specialty Surgery

    /Admin/ADVANCED GRAPHICS FILES/Cover and Template/2026/2026_03/4714660-001_Integra_Chelsea Lin_Dividers Specialty Surgery 02 These materials are not to be printed, downloaded or distributed. These materials are only available to QIBs and non-US persons.

  13. Slide 13: Specialty Surgery overview

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  14. Slide 14: Neuro: We deliver broader and deeper solutions

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  15. Slide 15: ENT and Instruments: We deliver broader and deeper solutions

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  16. Slide 16: Global market position and trend by platform

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  17. Slide 17: Accelerate growth: Specialty Surgery

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  18. Slide 18: Specialty Surgery: Addressing complex pathologies in neurosurgery

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  19. Slide 19: Category-leading technologies fueled by scale and resilience

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  20. Slide 20: Tissue Reconstruction

    /Admin/ADVANCED GRAPHICS FILES/Cover and Template/2026/2026_03/4714660-001_Integra_Chelsea Lin_Dividers Tissue Reconstruction 03 These materials are not to be printed, downloaded or distributed. These materials are only available to QIBs and non-US persons.

  21. Slide 21: Poised for Growth in Attractive Global Markets

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  22. Slide 22: Wound Reconstruction Solutions

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  23. Slide 23: Soft Tissue Solutions

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  24. Slide 24: Global market position and trend by platform

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  25. Slide 25: Prioritizing four strategies to deliver innovation and organic growth

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  26. Slide 26: Tissue Reconstruction: Leading the way in regenerative technologies

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  27. Slide 27: CMS Reimbursement Reform 2026

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  28. Slide 28: 2026 recovering from previous operational headwinds

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  29. Slide 29: Supply Chain / Operations

    /Admin/ADVANCED GRAPHICS FILES/Cover and Template/2026/2026_03/4714660-001_Integra_Chelsea Lin_Dividers Supply Chain / Operations 04 These materials are not to be printed, downloaded or distributed. These materials are only available to QIBs and non-US persons.

  30. Slide 30: Global manufacturing and distribution footprint

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  31. Slide 31: Overview of state-of-the-art facilities

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  32. Slide 32: Key Capabilities to Drive Operations and Customer Excellence

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  33. Slide 33: Summary of global operations opportunity

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  34. Slide 34: Remediation update

    /Admin/ADVANCED GRAPHICS FILES/Cover and Template/2026/2026_03/4714660-001_Integra_Chelsea Lin_Dividers Remediation update 05 These materials are not to be printed, downloaded or distributed. These materials are only available to QIBs and non-US persons.

  35. Slide 35: Beyond Remediation: Building a Stronger Quality and Operating Foundation

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  36. Slide 36: Path to full product reintroduction

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  37. Slide 37: Braintree: restoring supply and enabling recovery

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  38. Slide 38: Trailing twelve months across meaningful categories

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  39. Slide 39: Investment highlights

    /Admin/ADVANCED GRAPHICS FILES/Cover and Template/2026/2026_03/4714660-001_Integra_Chelsea Lin_Dividers Investment highlights 06 These materials are not to be printed, downloaded or distributed. These materials are only available to QIBs and non-US persons.

  40. Slide 40: Investment highlights summary

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  41. Slide 41: Global leader in neurosurgery and regenerative medicine

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  42. Slide 42: Global Opportunity

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  43. Slide 43: Diversified portfolio across various specialties

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  44. Slide 44: Significant brand equity and loyalty

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  45. Slide 45: Clear and methodical remediation plan well underway

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  46. Slide 46: Return to strong FCF generation and deleveraging

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  47. Slide 47: Seasoned leadership team with decades of MedTech experience

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  48. Slide 48: Financial summary

    /Admin/ADVANCED GRAPHICS FILES/Cover and Template/2026/2026_03/4714660-001_Integra_Chelsea Lin_Dividers Financial summary 07 These materials are not to be printed, downloaded or distributed. These materials are only available to QIBs and non-US persons.

  49. Slide 49: Financial policy

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  50. Slide 50: Historical operating performance

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  51. Slide 51: Historical credit metrics

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  52. Slide 52: Appendix

    /Admin/ADVANCED GRAPHICS FILES/Cover and Template/2026/2026_03/4714660-001_Integra_Chelsea Lin_Dividers Appendix 08 These materials are not to be printed, downloaded or distributed. These materials are only available to QIBs and non-US persons.

  53. Slide 53: Trailing twelve month EBITDA reconciliation

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

  54. Slide 54: Trailing twelve month FCF and adjusted gross margin reconciliation

    COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 179 212 Followed Hyperlink 30 105 142 143 202 231 Lines 31 73 12

Integra LifeSciences Holdings — Investor Presentation (September 2026) on 6ix